---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "ArchieMD IC Health Coronary Bypass"
developer_entity: "ArchieMD, Inc."
bundle_id: "com.archiemd.ichealth.bypass"
app_store_id: "592890302"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Freemium"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2015-07-07"
report_date: "2026-09-23"
last_verified: "2026-09-23T00:00:00.000Z"
report_version: "1.2"
total_reviews: 2
overall_rating: 5
confidence: "low"
confidence_score: 0.3
data_age_days: 49
momentum_velocity: "zombie"
intelligence_version: 2
tags: ["medical", "freemium", "mobile app", "app review", "app analysis", "patients", "preparing", "coronary"]
canonical_url: "https://marlvel.ai/apps/archiemd-ic-health-coronary-bypass"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# ArchieMD IC Health Coronary Bypass Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Freemium
- **Signal**: Rating 5

> **TL;DR:** ArchieMD IC Health Coronary Bypass is a medical app by ArchieMD, Inc., rated 5/5 by 2 users, available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** ArchieMD IC Health Coronary Bypass is a medical app by ArchieMD, Inc..
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 5/5 (2 reviews) |
| **Category** | Medical |
| **Developer** | ArchieMD, Inc. |
| **Pricing** | Freemium |
| **Platforms** | iOS |
| **Confidence** | Low (0.3/1.0) |
| **Data Age** | 49d |

## Metadata & Market Performance
- **Publisher:** ArchieMD, Inc.
- **Category:** Medical
- **Target Audience:** Patients preparing for coronary artery bypass surgery and medical trainees requiring interactive simulation-based education.
- **Platforms:** iOS
- **Version Reviewed:** 1.2
- **Report Date:** 2026-09-23
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.3/1.0)
- **App Store ID (iOS):** 592890302
- **Bundle ID:** com.archiemd.ichealth.bypass
- **Data Window:** Analysis based on signals collected up to 2026-09-23

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** ArchieMD IC Health Coronary Bypass is a medical education app for iOS that uses 3D simulations to explain coronary artery bypass procedures to patients and trainees.
**Why users hire it:** The app removes the cognitive friction of understanding complex surgical procedures by providing interactive visual modules that replace static medical pamphlets.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Interactive Medical Simulation:** 3D visualizations of coronary artery bypass procedures.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Standard] Pre and Post-Operation Modules:** Educational content covering patient preparation and recovery phases.
- **[Differentiator] Performance Tracking:** System records trainee progress for review by instructors.
  * *User Intent:* Users seek enhanced value through premium features.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

ArchieMD IC Health Coronary Bypass maintains a niche presence in the medical category with a 5-star rating based on 2 reviews. The lack of updates for over 4,000 days positions it as a legacy tool rather than a competitive participant in the current health app market.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Freemium
- **Tiers:** Free version with limited access, $0.99 full content unlock
- **Analysis:** The freemium model uses a low-cost $0.99 IAP to convert users from a limited trial to full educational access.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Proprietary 3D graphics provide specialized training utility

**Growth Levers:**
- Pivot to B2B subscription for medical schools


<!-- /section:swot -->
<!-- section:whats-new -->
## What's New

- **Latest (v1.2, 11 years ago):** General bug fixes and stability improvements.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Dormant since 2015.
- No feature expansion in 11 years.

> **Cadence:** 1 total versions · 0 majors in last 6 months · 4095 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

ArchieMD IC Health Coronary Bypass is a medical app that is free with in-app purchases.
It holds a 5/5 rating from 2 reviews.

<!-- speakable-start -->
> **Bottom Line:** ArchieMD IC Health Coronary Bypass functions as a legacy asset that no longer receives active development, so the PM should prioritize sunsetting the product to focus resources on modern, cloud-integrated medical training platforms.
<!-- speakable-end -->

**Best for:** Patients preparing for coronary artery bypass surgery and medical trainees requiring interactive simulation-based education.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [SUNSET] Sunset the app because it has been dormant for over a decade → reduce brand risk from technical failure
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Declining

The medical education market is shifting toward cloud-based, frequently updated platforms that offer real-time data syncing. ArchieMD IC Health Coronary Bypass remains static, meaning it will lose all remaining utility as mobile hardware and software standards continue to advance.

- 🔴 The 11-year development silence indicates the product is abandoned, which will eventually lead to removal from the App Store as OS requirements evolve.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 5/5 |
| Total Reviews | 2 |
| Confidence | Low |
| Pricing Model | Freemium |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **ArchieMD IC Health Coronary Bypass** (this app) | 5/5 | N/A | ArchieMD, Inc. |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** ArchieMD, Inc.
- **Website:** [https://www.medrills.com](https://www.medrills.com)

## Data Sources & Links
- **App Store ID:** 592890302
- **Dev Site:** [Official Website](https://www.medrills.com)
- **Sources:** Developer website content, About us / company information, App store metadata.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 49 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/archiemd-ic-health-coronary-bypass)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.